Changes of clinical and biochemical parameters after treatment.

Baseline clinical, anthropometric, and biochemical characteristics of the study populations.

Agnieszka Zwolak (760122)
Olga Słabczyńska (832577)
Justyna Semeniuk (2547667)
Jadwiga Daniluk (832576)
Agnieszka Szuster-Ciesielska (832575)

March 2016

Baseline clinical, anthropometric, and biochemical characteristics of the study populations.</p

Baseline characteristics according to the change in fatty liver status over the follow-up period.

Jae-Uk Song (4831782)
Yoonjung Jang (4888105)
Si-Young Lim (6256478)
Seungho Ryu (164515)
Won Jun Song (6256481)
Christopher D. Byrne (114429)
Ki-Chul Sung (288184)

January 2019

Baseline characteristics according to the change in fatty liver status over the follow-up period.</p

Changes in the β and P values of age for AUCage after successively adjusting FPG, 2-h PG, eGFR, Hb and RBC count.

Li Wu (120770)
Huandong Lin (429083)
Jian Gao (307118)
Xiaoming Li (7401)
Mingfeng Xia (204842)
Dan Wang (34472)
Qiqige Aleteng (2826989)
Hui Ma (290168)
Baishen Pan (458539)
Xin Gao (14001)

September 2017

Changes in the β and P values of age for AUCage after successively adjusting FPG, 2-h PG, ...

Percentage changes of vascular and metabolic parameters compared with the baseline at each time point and P values of comparisons between the treated and control groups.

Su Yeon Ahn (753404)
Jin Mo Goo (507438)
Kyung Hee Lee (753401)
Seunggyun Ha (691221)
Jin Chul Paeng (621230)

February 2018

Percentage changes of vascular and metabolic parameters compared with the baseline at each time p...

Reduction of blood glucose, body weight and hepatic fat content after therapy.

Hong-Mei Yan (305065)
Ming-Feng Xia (781250)
Yan Wang (15435)
Xin-Xia Chang (781251)
Xiu-Zhong Yao (781252)
Sheng-Xiang Rao (781253)
Meng-Su Zeng (781254)
Yin-Fang Tu (781255)
Ru Feng (422848)
Wei-Ping Jia (54227)
Jun Liu (42548)
Wei Deng (17330)
Jian-Dong Jiang (346645)
Xin Gao (14001)

August 2015

Mean values are shown for percentage changes from baseline of A) FBG, B) PBG, C) body weight and ...

Hematological and biochemical changes over the course of treatment and during follow up.

Ahmed Nagaty (4494688)
Ekram W. Abd El-Wahab (3345380)

October 2017

Hematological and biochemical changes over the course of treatment and during follow up.</p

Anthropometric and metabolic values at baseline and after a 3 weeks period treatment.

Debora Fedele (633721)
Virginia Bicchiega (4246666)
Alessandro Collo (4246663)
Federica Barutta (479740)
Erika Pistone (4246660)
Gabriella Gruden (479748)
Graziella Bruno (479744)

July 2017

Anthropometric and metabolic values at baseline and after a 3 weeks period treatment.</p

Clinical-biochemical parameters and drug treatment of hypertensive patients at start (baseline) and after treatment intensification during 12 months.

Charbel Maroun-Eid (4739415)
Adriana Ortega-Hernández (4739412)
Javier Modrego (500534)
María Abad-Cardiel (4739409)
José Antonio García-Donaire (4739424)
Leonardo Reinares (4739427)
Nieves Martell-Claros (4739421)
Dulcenombre Gómez-Garre (4739418)

January 2018

Clinical-biochemical parameters and drug treatment of hypertensive patients at start (baseline) a...

The effects of BMI change during follow-up, adjusted for baseline variables.

Sandra H. van Oostrom (2189905)
Peter M. Engelfriet (613984)
W. M. Monique Verschuren (304931)
Maarten Schipper (508738)
Inge M. Wouters (320143)
Marike Boezen (5227757)
Henriëtte A. Smit (5227754)
Huib A. M. Kerstjens (204289)
H. Susan J. Picavet (548903)

May 2018

The effects of BMI change during follow-up, adjusted for baseline variables.</p

Changes from the baseline values in blood pressure at the end of the treatment period (FAS).

Mitsuhide Naruse (6551468)
Yasuhiro Koike (6551471)
Nozomu Kamei (501277)
Ryuichi Sakamoto (6551474)
Yuko Yambe (6551477)
Michinori Arimitsu (6551480)

April 2019

Changes from the baseline values in blood pressure at the end of the treatment period (FAS).</p

Clinical and biochemical parameters for both the overall population and the Survivors and non-Survivors subgroups.

Gianluca Villa (3753742)
Cosimo Chelazzi (3753736)
Elena Morettini (2844728)
Lucia Zamidei (3753724)
Serafina Valente (3753733)
A. Lucia Caldini (3753730)
Giovanni Zagli (3753727)
A. Raffaele De Gaudio (3753739)
Stefano Romagnoli (2816854)

February 2017

Clinical and biochemical parameters for both the overall population and the Survivors and non-Sur...

BMI change between baseline and follow-up, overall and according to health perception at baseline.

Rodrigo M. Carrillo-Larco (660163)
Antonio Bernabe-Ortiz (90790)
J. Jaime Miranda (10703)
Hong Xue (28736)
Youfa Wang (302429)

April 2017

BMI change between baseline and follow-up, overall and according to health perception at baseline...

Age-adjusted mean values for patient characteristics at baseline year according to eGFR category.

Kei Nagai (467416)
Toshimi Sairenchi (216378)
Fujiko Irie (216346)
Hiroshi Watanabe (81742)
Hitoshi Ota (2172598)
Kunihiro Yamagata (413551)

June 2016

Age-adjusted mean values for patient characteristics at baseline year according to eGFR category....

Clinical and biochemical parameters in C-group and H-group at Baseline and Follow-up Visit.

Concetta Irace (739030)
Antonio Cutruzzolà (6425195)
Delia Francesca Carbotti (6425198)
Simona Mastroianni (6425201)
Michela Cavallo (6425204)
Agostino Gnasso (739031)

March 2019

Clinical and biochemical parameters in C-group and H-group at Baseline and Follow-up Visit.</p

Absolute levels of biochemical parameters at baseline and at the various time points.

Fassio Angelo

June 2021

Absolute levels and % change in biochemical parameters at baseline and at the various time points in...

Baseline clinical, anthropometric, and biochemical characteristics of the study populations.

Agnieszka Zwolak (760122)
Olga Słabczyńska (832577)
Justyna Semeniuk (2547667)
Jadwiga Daniluk (832576)
Agnieszka Szuster-Ciesielska (832575)

March 2016

Baseline clinical, anthropometric, and biochemical characteristics of the study populations.</p

Baseline characteristics according to the change in fatty liver status over the follow-up period.

Jae-Uk Song (4831782)
Yoonjung Jang (4888105)
Si-Young Lim (6256478)
Seungho Ryu (164515)
Won Jun Song (6256481)
Christopher D. Byrne (114429)
Ki-Chul Sung (288184)

January 2019

Baseline characteristics according to the change in fatty liver status over the follow-up period.</p

Changes in the β and P values of age for AUCage after successively adjusting FPG, 2-h PG, eGFR, Hb and RBC count.

Li Wu (120770)
Huandong Lin (429083)
Jian Gao (307118)
Xiaoming Li (7401)
Mingfeng Xia (204842)
Dan Wang (34472)
Qiqige Aleteng (2826989)
Hui Ma (290168)
Baishen Pan (458539)
Xin Gao (14001)

September 2017

Changes in the β and P values of age for AUCage after successively adjusting FPG, 2-h PG, ...

Percentage changes of vascular and metabolic parameters compared with the baseline at each time point and P values of comparisons between the treated and control groups.

Su Yeon Ahn (753404)
Jin Mo Goo (507438)
Kyung Hee Lee (753401)
Seunggyun Ha (691221)
Jin Chul Paeng (621230)

February 2018

Percentage changes of vascular and metabolic parameters compared with the baseline at each time p...

Reduction of blood glucose, body weight and hepatic fat content after therapy.

Hong-Mei Yan (305065)
Ming-Feng Xia (781250)
Yan Wang (15435)
Xin-Xia Chang (781251)
Xiu-Zhong Yao (781252)
Sheng-Xiang Rao (781253)
Meng-Su Zeng (781254)
Yin-Fang Tu (781255)
Ru Feng (422848)
Wei-Ping Jia (54227)
Jun Liu (42548)
Wei Deng (17330)
Jian-Dong Jiang (346645)
Xin Gao (14001)

August 2015

Mean values are shown for percentage changes from baseline of A) FBG, B) PBG, C) body weight and ...

Hematological and biochemical changes over the course of treatment and during follow up.

Ahmed Nagaty (4494688)
Ekram W. Abd El-Wahab (3345380)

October 2017

Hematological and biochemical changes over the course of treatment and during follow up.</p

Anthropometric and metabolic values at baseline and after a 3 weeks period treatment.

Debora Fedele (633721)
Virginia Bicchiega (4246666)
Alessandro Collo (4246663)
Federica Barutta (479740)
Erika Pistone (4246660)
Gabriella Gruden (479748)
Graziella Bruno (479744)

July 2017

Anthropometric and metabolic values at baseline and after a 3 weeks period treatment.</p

Clinical-biochemical parameters and drug treatment of hypertensive patients at start (baseline) and after treatment intensification during 12 months.

Charbel Maroun-Eid (4739415)
Adriana Ortega-Hernández (4739412)
Javier Modrego (500534)
María Abad-Cardiel (4739409)
José Antonio García-Donaire (4739424)
Leonardo Reinares (4739427)
Nieves Martell-Claros (4739421)
Dulcenombre Gómez-Garre (4739418)

January 2018

Clinical-biochemical parameters and drug treatment of hypertensive patients at start (baseline) a...

The effects of BMI change during follow-up, adjusted for baseline variables.

Sandra H. van Oostrom (2189905)
Peter M. Engelfriet (613984)
W. M. Monique Verschuren (304931)
Maarten Schipper (508738)
Inge M. Wouters (320143)
Marike Boezen (5227757)
Henriëtte A. Smit (5227754)
Huib A. M. Kerstjens (204289)
H. Susan J. Picavet (548903)

May 2018

The effects of BMI change during follow-up, adjusted for baseline variables.</p

Changes from the baseline values in blood pressure at the end of the treatment period (FAS).

Mitsuhide Naruse (6551468)
Yasuhiro Koike (6551471)
Nozomu Kamei (501277)
Ryuichi Sakamoto (6551474)
Yuko Yambe (6551477)
Michinori Arimitsu (6551480)

April 2019

Changes from the baseline values in blood pressure at the end of the treatment period (FAS).</p

Clinical and biochemical parameters for both the overall population and the Survivors and non-Survivors subgroups.

Gianluca Villa (3753742)
Cosimo Chelazzi (3753736)
Elena Morettini (2844728)
Lucia Zamidei (3753724)
Serafina Valente (3753733)
A. Lucia Caldini (3753730)
Giovanni Zagli (3753727)
A. Raffaele De Gaudio (3753739)
Stefano Romagnoli (2816854)

February 2017

Clinical and biochemical parameters for both the overall population and the Survivors and non-Sur...

BMI change between baseline and follow-up, overall and according to health perception at baseline.

Rodrigo M. Carrillo-Larco (660163)
Antonio Bernabe-Ortiz (90790)
J. Jaime Miranda (10703)
Hong Xue (28736)
Youfa Wang (302429)

April 2017

BMI change between baseline and follow-up, overall and according to health perception at baseline...

Age-adjusted mean values for patient characteristics at baseline year according to eGFR category.

Kei Nagai (467416)
Toshimi Sairenchi (216378)
Fujiko Irie (216346)
Hiroshi Watanabe (81742)
Hitoshi Ota (2172598)
Kunihiro Yamagata (413551)

June 2016

Age-adjusted mean values for patient characteristics at baseline year according to eGFR category....

Clinical and biochemical parameters in C-group and H-group at Baseline and Follow-up Visit.

Concetta Irace (739030)
Antonio Cutruzzolà (6425195)
Delia Francesca Carbotti (6425198)
Simona Mastroianni (6425201)
Michela Cavallo (6425204)
Agostino Gnasso (739031)

March 2019

Clinical and biochemical parameters in C-group and H-group at Baseline and Follow-up Visit.</p

Absolute levels of biochemical parameters at baseline and at the various time points.

Fassio Angelo

June 2021

Absolute levels and % change in biochemical parameters at baseline and at the various time points in...

Baseline clinical, anthropometric, and biochemical characteristics of the study populations.

Agnieszka Zwolak (760122)
Olga Słabczyńska (832577)
Justyna Semeniuk (2547667)
Jadwiga Daniluk (832576)
Agnieszka Szuster-Ciesielska (832575)

March 2016

Baseline clinical, anthropometric, and biochemical characteristics of the study populations.</p

Baseline characteristics according to the change in fatty liver status over the follow-up period.

Jae-Uk Song (4831782)
Yoonjung Jang (4888105)
Si-Young Lim (6256478)
Seungho Ryu (164515)
Won Jun Song (6256481)
Christopher D. Byrne (114429)
Ki-Chul Sung (288184)

January 2019

Baseline characteristics according to the change in fatty liver status over the follow-up period.</p

Changes in the β and P values of age for AUCage after successively adjusting FPG, 2-h PG, eGFR, Hb and RBC count.

Li Wu (120770)
Huandong Lin (429083)
Jian Gao (307118)
Xiaoming Li (7401)
Mingfeng Xia (204842)
Dan Wang (34472)
Qiqige Aleteng (2826989)
Hui Ma (290168)
Baishen Pan (458539)
Xin Gao (14001)

September 2017

Changes in the β and P values of age for AUCage after successively adjusting FPG, 2-h PG, ...

Changes of clinical and biochemical parameters after treatment.

Abstract

Extracted data

Changes of clinical and biochemical parameters after treatment.

Abstract

Extracted data

Related items

Related items